Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Using annuities and stocks for retirement income explains blending these assets to diversify risk and stabilize cash flow for retirement.
28,656 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
After a quarterly report, Netflix's post-earnings sell-off just highlighted a shift in strategy. This article breaks ...
GameStop is weighing a bold move: acquiring eBay. This article breaks down whether does Gamestop's proposed acquisiti...
Alphabet is planning to raise a substantial sum from stock sales, including private placements, convertible securitie...
A massive AI spending wave among hyperscalers could redefine markets. Discover why billionaire Bill Ackman is placing...
Apple launched the MacBook Neo at a budget price, signaling a potential breakthrough for Mac demand. This article bre...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...
As Angiodynamics (ANGO) gears up for the 2026 earnings season, investors should focus on orders, backlog, margins, an...
Looking ahead at geron (gern) 2026 earnings, this guide breaks down the catalysts, cash runway, and risks shaping the...
Beyond Meat is shifting from plant-based meat to protein drinks. This article explores whether beyond meat's pivot pr...
What to watch as J.B. Hunt moves into 2026. This analysis breaks down the Q2 dynamics, segment performance, and what ...
As Innodata prepares to unveil its Q1 2026 results, investors want clarity on growth drivers, margins, and the path t...